Lonza, 00219736, P-HDF-Diseased Human Dermal Fibroblast (Lesion)

Product Overview Psoriasis is believed to be an immune related condition characterized by patches of abnormal skin. Psoriasis is chronic, lasting years or even an entire lifetime, and impacts millions of individuals every year. Psoriasis is believed to have a genetic component, however, scientists are still uncertain what specifically causes the disease. For individuals with psoriasis, skin cells grow at an abnormal rate causing the build-up of lesion sites. These flair-ups are often initiated by a trigger such as stress or injury. Lonza offers dermal fibroblasts, isolated from both lesion sites and non-lesion sites, all isolated from the same donor diagnosed with psoriasis. Catalog no. 219736 (Lot no. 6F5008) Donor Information: 69 year old Caucasian male Disease: Psoriasis (Lesion Site Derived) Culture Media: Lonza FGM TM-2 Fibroblast Growth Medium BulletKit (Lonza Cat. No. CC-3132) Culture Conditions: Culture following Lonza's Standard Protocol for culturing Human Fibroblasts Quality Control Testing: Seeding Efficiency (26%), Cell Count (582,000 cells/vial), Viability (97%), doubling time (51 hours), HIV/HBV, HCV/Mycoplasma (not detected), Sterility (negative) This product is classified as a Limited Edition Cell Type. Lonza CellBio Services occasionally obtains excess or additional cells from custom isolations that can be offered as individual cryopreserved vials. These Limited Edition Cells are available in limited inventory and may not be available again after inventory is depleted. Request More Info
Storage and Content 1 x Cryopreserved Ampule with ≥500,000 cells/vial Store at-180 C